JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 26, 2004; DOI: 10.1124/jpet.103.064154


0022-3565/04/3093-869-878$20.00
JPET 309:869-878, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.064154v1
309/3/869    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Z.-Q.
Right arrow Articles by Salvemini, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.-Q.
Right arrow Articles by Salvemini, D.

NEUROPHARMACOLOGY

A Newly Identified Role for Superoxide in Inflammatory Pain

Zhi-Qiang Wang, Frank Porreca, Salvatore Cuzzocrea, Karen Galen, Richard Lightfoot, Emanuela Masini, Carolina Muscoli, Vincenzo Mollace, Michael Ndengele, Harry Ischiropoulos, and Daniela Salvemini

Department of Biological and Pharmacological Research, Metaphore Pharmaceuticals, St. Louis, Missouri (Z.-Q.W., K.G., C.M., M.N., D.S.); Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona (F.P.); Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy (S.C.); Stokes Research Institute, Children's Hospital of Pennsylvania and University of Pennsylvania, Philadelphia, Pennsylvania (R.L., H.I.); Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy (E.M.); and the Faculty of Pharmacy, University of Catanzaro "Magna Graecia", Roccelletta di Borgia, Catanzaro, Italy (C.M., V.M.).

Novel classes of pain-relieving molecules are needed to fill the void between nonsteroidal anti-inflammatory agents and narcotics. Our studies have identified superoxide as a novel mediator of hyperalgesia (clinically defined as an augmented sensitivity to painful stimuli) and have exposed potential pathways through which this radical modulates the hyperalgesic response. The role of superoxide in pain was elucidated using a superoxide dismutase mimetic, M40403 [a manganese(II) complex with a bis(cyclo-hexylpyridine-substituted) macrocyclic ligand]. Intraplantar injection of carrageenan in rats led to time-dependent development of peripheral inflammation [measured parameters of inflammation included paw edema, cytokine release in the paw exudates, nitrotyrosine formation (a marker of peroxynitrite formation and oxidative stress), and poly-ADP-ribose-polymerase activation (the nuclear enzyme activated by superoxide/peroxynitrite)] and hyperalgesia. M40403 blocked all measured parameters of inflammation and hyperalgesia. Furthermore, when given therapeutically (2 h after the induction of hyperalgesia) either by intravenous or intrathecal administration, M40403 but not its inactive congener M40404 inhibited hyperalgesia with a rapid onset of action. Our results also show that, at the level of the spinal cord and time of peak hyperalgesia, endogenous manganese superoxide dismutase was nitrated and subsequently deactivated, losing its capacity to remove superoxide. The antihyperalgesic effects of M40403 were not reversed by naloxone excluding the potential involvement of an opiate pathway. Collectively, these studies have unraveled a critical role for superoxide in the nociceptive signaling cascade both peripherally and centrally. The discovery of this pathway opens a new therapeutic strategy for the development of novel nonnarcotic antihyperalgesic agents.


Received December 11, 2003; accepted February 24, 2004.

Address correspondence to: Dr. Daniela Salvemini, Department of Biological and Pharmacological Research, Metaphore Pharmaceuticals, 1910 Innerbelt Business Center Drive, St. Louis, MO 63114. E-mail: dsalvemini{at}metaphore.com.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. S. Schwartz, H. Y. Kim, J. Wang, I. Lee, E. Klann, J. M. Chung, and K. Chung
Persistent Pain Is Dependent on Spinal Mitochondrial Antioxidant Levels
J. Neurosci., January 7, 2009; 29(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Ibi, K. Matsuno, D. Shiba, M. Katsuyama, K. Iwata, T. Kakehi, T. Nakagawa, K. Sango, Y. Shirai, T. Yokoyama, et al.
Reactive Oxygen Species Derived from NOX1/NADPH Oxidase Enhance Inflammatory Pain
J. Neurosci., September 17, 2008; 28(38): 9486 - 9494.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. M. Ndengele, S. Cuzzocrea, E. Esposito, E. Mazzon, R. Di Paola, G. M. Matuschak, and D. Salvemini
Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity
FASEB J, September 1, 2008; 22(9): 3154 - 3164.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. M. Cunha, W. A. Verri Jr., I. R. Schivo, M. H. Napimoga, C. A. Parada, S. Poole, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha
Crucial role of neutrophils in the development of mechanical inflammatory hypernociception
J. Leukoc. Biol., April 1, 2008; 83(4): 824 - 832.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
I Avalos, C P Chung, A Oeser, G L Milne, J D Morrow, T Gebretsadik, A Shintani, C Yu, and C M Stein
Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms
Lupus, March 1, 2007; 16(3): 195 - 200.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
T.-L. Tsai, S.-Y. Chang, C.-Y. Ho, and Y. R. Kou
Neural and hydroxyl radical mechanisms underlying laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats
J Appl Physiol, July 1, 2006; 101(1): 328 - 338.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
W. H. Lee and Y. H. Lee
26406 - REACTIVE OXYGEN SPECIES (ROS) SCAVENGER EXHIBITS ANTINOCICEPTIVE PROPERTIES IN THE RAT (SPRAGUE-DAWLEY) FORMALIN TEST.
Can J Anesth, June 1, 2006; 53(suppl_1): 26406 - 26406.
[Full Text] [PDF]


Home page
Mol. Interv.Home page
J. M. Chung
The Role of Reactive Oxygen Species (ROS) in Persistent Pain
Mol. Interv., October 1, 2004; 4(5): 248 - 250.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.